OOIR: Observatory of International Research

Papers

(The H4-Index of BMJ Open Diabetes Research & Care is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Cardiovascular disease risk factors and their associations with inflammation among US adolescents: NHANES, 2015 to March 2020	101
Offloading devices for neuropathic foot ulcers in adult persons with type 1 or type 2 diabetes: a rapid review with meta-analysis and trial sequential analysis of randomized controlled trials	71
Association between RDW-SD and prognosis across glycemic status in patients with dilated cardiomyopathy	60
Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohort	60
Diagnostic accuracy of the 5.07 monofilament test for diabetes polyneuropathy: influence of age, sex, neuropathic pain and neuropathy severity	58
Longitudinal associations between family conflict, parent engagement, and metabolic control in children with recent-onset type 1 diabetes	53
Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes	53
Changes in granule mobility and age contribute to changes in insulin secretion after desensitization or rest	51
Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes	50
Characterization of the zebrafish as a model of ATP-sensitive potassium channel hyperinsulinism	50
Effects of insonification on repairing the renal injury of diabetic nephropathy rats	49
Biobanking in Latinos: current status, principles for conduct, and contribution of a new biobank, El Banco por Salud, designed to improve the health of Latino patients of Mexican ancestry with type 2	44
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial	41
Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey	34
Association of body indices and risk of mortality in patients with type 2 diabetes	33
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC	32
Association of hemoglobin A1c time in range with risk for diabetes complications	32
Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study	32
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK	31
Effects of concurrent aerobic and strength training in patients with type 2 diabetes: Bayesian pairwise and dose-response meta-analysis	31
Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study	30
Random plasma glucose levels and cause-specific mortality among Chinese adults without known diabetes: an 11-year prospective study of 450,000 people	30
Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments	30
Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus	30
Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study	28

Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study	28
Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy	28
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New Zealand	27